Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 539

1.

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.

Hanna GJ, Busaidy NL, Chau NG, Wirth LJ, Barletta JA, Calles A, Haddad RI, Kraft S, Cabanillas ME, Rabinowits G, O'Neill A, Limaye SA, Alexander EK, Moore FD Jr, Misiwkeiwicz K, Thomas T, Nehs M, Marqusee E, Lee SL, Jänne PA, Lorch JH.

Clin Cancer Res. 2018 Apr 1;24(7):1546-1553. doi: 10.1158/1078-0432.CCR-17-2297. Epub 2018 Jan 4.

PMID:
29301825
2.

Differential Growth Rates of Benign vs. Malignant Thyroid Nodules.

Angell TE, Vyas CM, Medici M, Wang Z, Barletta JA, Benson CB, Cibas ES, Cho NL, Doherty GM, Doubilet PM, Frates MC, Gawande AA, Heller HT, Kim MI, Krane JF, Marqusee E, Moore FD Jr, Nehs MA, Zavacki AM, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4642-4647. doi: 10.1210/jc.2017-01832.

PMID:
29040691
3.

Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.

Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs MA, Gawande AA, Moore FD Jr, Howitt BE, Strickland KC, Krane JF, Barletta JA, Cho NL.

J Am Coll Surg. 2017 Jun;224(6):1021-1027. doi: 10.1016/j.jamcollsurg.2016.12.007. Epub 2016 Dec 23.

PMID:
28017809
4.

Blockade of IgM-Mediated Inflammation Alters Wound Progression in a Swine Model of Partial-Thickness Burn.

Sadeghipour H, Torabi R, Gottschall J, Lujan-Hernandez J, Sachs DH, Moore FD Jr, Cetrulo CL Jr.

J Burn Care Res. 2017 May/Jun;38(3):148-160. doi: 10.1097/BCR.0000000000000459.

PMID:
27801682
5.

Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.

Gibson WJ, Ruan DT, Paulson VA, Barletta JA, Hanna GJ, Kraft S, Calles A, Nehs MA, Moore FD Jr, Taylor-Weiner A, Wala JA, Zack TI, Lee TC, Fennessy FM, Alexander EK, Thomas T, Janne PA, Garraway LA, Carter SL, Beroukhim R, Lorch JH, Van Allen EM.

Clin Cancer Res. 2017 May 1;23(9):2367-2373. doi: 10.1158/1078-0432.CCR-16-2154-T. Epub 2016 Oct 17.

PMID:
27797976
6.

Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.

Kakarmath S, Heller HT, Alexander CA, Cibas ES, Krane JF, Barletta JA, Lindeman NI, Frates MC, Benson CB, Gawande AA, Cho NL, Nehs M, Moore FD, Marqusee E, Kim MI, Larsen PR, Kwong N, Angell TE, Alexander EK.

J Clin Endocrinol Metab. 2016 Dec;101(12):4938-4944. Epub 2016 Sep 30.

7.

Features and Outcome of Autonomous Thyroid Nodules in Children: 31 Consecutive Patients Seen at a Single Center.

Ly S, Frates MC, Benson CB, Peters HE, Grant FD, Drubach LA, Voss SD, Feldman HA, Smith JR, Barletta J, Hollowell M, Cibas ES, Moore FD Jr, Modi B, Shamberger RC, Huang SA.

J Clin Endocrinol Metab. 2016 Oct;101(10):3856-3862. Epub 2016 Aug 8.

8.

Prevention of intestinal ischemia-reperfusion injury in humanized mice.

Sheu EG, Wakatsuki K, Oakes S, Carroll MC, Moore FD Jr.

Surgery. 2016 Aug;160(2):436-42. doi: 10.1016/j.surg.2016.03.001. Epub 2016 Apr 15.

9.

Identification of Novel Oncogenic Mutations in Thyroid Cancer.

Pitt SC, Hernandez RA, Nehs MA, Gawande AA, Moore FD Jr, Ruan DT, Cho NL.

J Am Coll Surg. 2016 Jun;222(6):1036-1043.e2. doi: 10.1016/j.jamcollsurg.2015.12.047. Epub 2016 Jan 14.

PMID:
27010584
10.

The variable phenotype and low-risk nature of RAS-positive thyroid nodules.

Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Frates MC, Benson CB, Cibas ES, Barletta JA, Krane JF, Ruan DT, Cho NL, Gawande AA, Moore FD Jr, Alexander EK.

BMC Med. 2015 Aug 7;13:184. doi: 10.1186/s12916-015-0419-z.

11.

Primary hyperparathyroidism after Roux-en-Y gastric bypass.

Chen Y, Lubitz CC, Shikora SA, Hodin RA, Gaz RD, Moore FD Jr, McKenzie TJ.

Obes Surg. 2015 Apr;25(4):700-4. doi: 10.1007/s11695-014-1444-2.

PMID:
25248510
12.

False negative cytology in large thyroid nodules.

Giles WH, Maclellan RA, Gawande AA, Ruan DT, Alexander EK, Moore FD Jr, Cho NL.

Ann Surg Oncol. 2015 Jan;22(1):152-7. doi: 10.1245/s10434-014-3952-7. Epub 2014 Jul 30.

PMID:
25074665
13.

Invited commentary.

Moore FD Jr.

J Am Coll Surg. 2014 Jun;218(6):1237-8. doi: 10.1016/j.jamcollsurg.2014.03.015. No abstract available.

PMID:
24840694
14.

How are childhood thyroid nodules discovered: opportunities for improving early detection.

Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, Wassner AJ, Smith JR, Marqusee E, Alexander EK, Barletta J, Muyide F, Doubilet PM, Peters HE, Webb S, Modi BP, Paltiel HJ, Martins Y, Burmeister K, Kozakewich H, Hollowell M, Cibas ES, Moore FD Jr, Shamberger RC, Larsen PR, Huang SA.

J Pediatr. 2014 Mar;164(3):658-60. doi: 10.1016/j.jpeds.2013.10.090. Epub 2013 Dec 15.

15.

Surgeons and patients disagree on the potential consequences from hypoparathyroidism.

Cho NL, Moalem J, Chen L, Lubitz CC, Moore FD Jr, Ruan DT.

Endocr Pract. 2014 May;20(5):427-46. doi: 10.4158/EP13321.OR.

PMID:
24325999
16.

Recalcitrant hypocalcemia after thyroidectomy in patients with previous Roux-en-Y gastric bypass.

McKenzie TJ, Chen Y, Hodin RA, Shikora SA, Hutter MM, Gaz RD, Moore FD Jr, Lubitz CC.

Surgery. 2013 Dec;154(6):1300-6; discussion 1306. doi: 10.1016/j.surg.2013.04.031. Epub 2013 Aug 23.

17.

A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.

Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, Wassner AJ, Smith JR, Marqusee E, Alexander EK, Barletta J, Doubilet PM, Peters HE, Webb S, Modi BP, Paltiel HJ, Kozakewich H, Cibas ES, Moore FD Jr, Shamberger RC, Larsen PR, Huang SA.

J Clin Endocrinol Metab. 2013 Aug;98(8):3238-45. doi: 10.1210/jc.2013-1796. Epub 2013 Jun 4.

18.

Bilateral neck exploration decreases operative time compared to minimally invasive parathyroidectomy in patients with discordant imaging.

Nehs MA, Ruan DT, Gawande AA, Moore FD Jr, Cho NL.

World J Surg. 2013 Jul;37(7):1614-7. doi: 10.1007/s00268-013-2007-8.

PMID:
23519294
19.

Thyroid nodule size and prediction of cancer.

Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, Benson CB, Doubilet PM, Cibas ES, Barletta J, Cho N, Gawande A, Ruan D, Moore FD Jr, Pou K, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2013 Feb;98(2):564-70. doi: 10.1210/jc.2012-2968. Epub 2012 Dec 28.

PMID:
23275525
20.

Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers.

Cho NL, Lin CI, Du J, Whang EE, Ito H, Moore FD Jr, Ruan DT.

Biochem Biophys Res Commun. 2012 May 11;421(3):508-13. doi: 10.1016/j.bbrc.2012.04.034. Epub 2012 Apr 10.

PMID:
22521882
21.

Bronchogenic cyst masquerading as an adrenal tumor: a case of mistaken identity.

O'Neal PB, Moore FD, Gawande A, Cho NL, King EE, Moalem J, Ruan D.

Endocr Pract. 2012 Sep-Oct;18(5):e102-5. doi: 10.4158/EP11186.CR. Review.

PMID:
22440987
22.

Hemorrhagic shock as the initial manifestation of pheochromocytoma: report of a sequential management strategy.

O'Neal PB, Moore FD Jr, Gawande A, Cho NL, Moalem J, Ruan DT.

Endocr Pract. 2012 Jul-Aug;18(4):e81-4. doi: 10.4158/EP11149.CR.

PMID:
22440984
23.

Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.

Lin CI, Barletta JA, Nehs MA, Morris ZS, Donner DB, Whang EE, Jeong JW, Kimura S, Moore FD Jr, Ruan DT.

Surgery. 2011 Dec;150(6):1295-302. doi: 10.1016/j.surg.2011.09.014.

24.

Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.

Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, Moore FD Jr, Hodin RA, Stephen AE, Sadow PM, Daniels GH, Randolph GW, Parangi S, Lubitz CC.

Surgery. 2011 Dec;150(6):1168-77. doi: 10.1016/j.surg.2011.09.043.

25.

Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.

Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, Moalem J, Moore FD Jr, Ruan DT.

Surgery. 2011 Dec;150(6):1032-9. doi: 10.1016/j.surg.2011.09.012.

PMID:
22136818
26.

Critical role of identification of the second gland during unilateral parathyroid surgery: a prospective review of 119 patients with concordant localization.

Cho NL, Gawande AA, Sheu EG, Moore FD Jr, Ruan DT.

Arch Surg. 2011 May;146(5):512-6. doi: 10.1001/archsurg.2011.91.

PMID:
21576603
27.

Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.

Lin CI, Du J, Shen WT, Whang EE, Donner DB, Griff N, He F, Moore FD Jr, Clark OH, Ruan DT.

J Clin Endocrinol Metab. 2011 Mar;96(3):E554-65. doi: 10.1210/jc.2010-1800. Epub 2010 Dec 29.

PMID:
21190978
28.

The predictive value of the fine-needle aspiration diagnosis "suspicious for a follicular neoplasm, hurthle cell type" in patients with hashimoto thyroiditis.

Roh MH, Jo VY, Stelow EB, Faquin WC, Zou KH, Alexander EK, Larsen PR, Marqusee E, Benson CB, Frates MC, Gawande A, Moore FD Jr, Cibas ES.

Am J Clin Pathol. 2011 Jan;135(1):139-45. doi: 10.1309/AJCP0RW2WMDUAKGK.

PMID:
21173136
29.

Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism.

Lubitz CC, Hunter GJ, Hamberg LM, Parangi S, Ruan D, Gawande A, Gaz RD, Randolph GW, Moore FD Jr, Hodin RA, Stephen AE.

Surgery. 2010 Dec;148(6):1129-37; discussion 1137-8. doi: 10.1016/j.surg.2010.09.002.

PMID:
21134543
30.

The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5.

Younan G, Suber F, Xing W, Shi T, Kunori Y, Abrink M, Pejler G, Schlenner SM, Rodewald HR, Moore FD Jr, Stevens RL, Adachi R, Austen KF, Gurish MF.

J Immunol. 2010 Dec 15;185(12):7681-90. doi: 10.4049/jimmunol.1002803. Epub 2010 Nov 12.

31.

Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer.

Lin CI, Whang EE, Donner DB, Du J, Lorch J, He F, Jiang X, Price BD, Moore FD Jr, Ruan DT.

Mol Cancer Res. 2010 Sep;8(9):1217-26. doi: 10.1158/1541-7786.MCR-10-0162. Epub 2010 Aug 24.

32.

Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.

Cho NL, Lin CI, Whang EE, Carothers AM, Moore FD Jr, Ruan DT.

Thyroid. 2010 Jun;20(6):615-22. doi: 10.1089/thy.2009.0415.

PMID:
20470206
33.

Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction.

Haas MS, Alicot EM, Schuerpf F, Chiu I, Li J, Moore FD, Carroll MC.

Cardiovasc Res. 2010 Sep 1;87(4):618-27. doi: 10.1093/cvr/cvq141. Epub 2010 May 11.

34.

Inhibition of rat gut reperfusion injury with an agent developed for the mouse. Evidence that amplification of injury by innate immunity is conserved between two animal species.

Afnan J, Ahmadi-Yazdi C, Sheu EG, Oakes SM, Moore FD Jr.

Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1675-81. doi: 10.1152/ajpregu.00380.2009. Epub 2010 Mar 24.

35.

Career satisfaction of women in surgery: perceptions, factors, and strategies.

Ahmadiyeh N, Cho NL, Kellogg KC, Lipsitz SR, Moore FD Jr, Ashley SW, Zinner MJ, Breen EM.

J Am Coll Surg. 2010 Jan;210(1):23-8. doi: 10.1016/j.jamcollsurg.2009.08.011. Epub 2009 Oct 2.

PMID:
20123327
36.

Autophagy: a new target for advanced papillary thyroid cancer therapy.

Lin CI, Whang EE, Abramson MA, Jiang X, Price BD, Donner DB, Moore FD Jr, Ruan DT.

Surgery. 2009 Dec;146(6):1208-14. doi: 10.1016/j.surg.2009.09.019.

PMID:
19958950
37.

Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.

Lin CI, Whang EE, Donner DB, Jiang X, Price BD, Carothers AM, Delaine T, Leffler H, Nilsson UJ, Nose V, Moore FD Jr, Ruan DT.

Mol Cancer Res. 2009 Oct;7(10):1655-62. doi: 10.1158/1541-7786.MCR-09-0274. Epub 2009 Oct 13.

38.

Restoration of skeletal muscle ischemia-reperfusion injury in humanized immunodeficient mice.

Sheu EG, Oakes SM, Ahmadi-Yazdi C, Afnan J, Carroll MC, Moore FD Jr.

Surgery. 2009 Aug;146(2):340-6. doi: 10.1016/j.surg.2009.06.010.

39.

Improved survival of murine island skin flaps by prevention of reperfusion injury.

Tatlidede SH, Murphy AD, McCormack MC, Nguyen JT, Eberlin KR, Randolph MA, Moore FD Jr, Austen WG Jr.

Plast Reconstr Surg. 2009 May;123(5):1431-9. doi: 10.1097/PRS.0b013e3181a071e8.

PMID:
19407613
40.

Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells.

Lin CI, Whang EE, Abramson MA, Donner DB, Bertagnolli MM, Moore FD Jr, Ruan DT.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):626-31. doi: 10.1016/j.bbrc.2008.12.153. Epub 2009 Jan 3.

PMID:
19124005
41.

Attenuation of the effects of rat hemorrhagic shock with a reperfusion injury-inhibiting agent specific to mice.

Ahmadi-Yazdi C, Williams B, Oakes S, Moore FD Jr.

Shock. 2009 Sep;32(3):295-301. doi: 10.1097/SHK.0b013e3181995e0c.

42.

Surgery for hyperparathyroidism in image-negative patients.

Chan RK, Ruan DT, Gawande AA, Moore FD Jr.

Arch Surg. 2008 Apr;143(4):335-7. doi: 10.1001/archsurg.143.4.335.

PMID:
18427019
43.

Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation.

Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK.

Cancer. 2007 Dec 25;111(6):508-16.

44.

Decay-accelerating factor attenuates remote ischemia-reperfusion-initiated organ damage.

Weeks C, Moratz C, Zacharia A, Stracener C, Egan R, Peckham R, Moore FD Jr, Tsokos GC.

Clin Immunol. 2007 Sep;124(3):311-27. Epub 2007 Jul 12.

PMID:
17631050
45.

Predicting future staffing needs at teaching hospitals: use of an analytical program with multiple variables.

Mitchell CC, Ashley SW, Zinner MJ, Moore FD Jr.

Arch Surg. 2007 Apr;142(4):329-34.

PMID:
17438166
46.

Innate response to self-antigen significantly exacerbates burn wound depth.

Suber F, Carroll MC, Moore FD Jr.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3973-7. Epub 2007 Feb 28.

47.

Are scintigraphy, ultrasonography, and the parathyroid hormone assay necessary to identify solitary parathyroid adenomas?

Moore FD Jr.

Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):214-5. Epub 2007 Jan 30. No abstract available.

PMID:
17262065
48.

Inherited aspects of papillary thyroid carcinoma.

Moore FD Jr.

J Surg Oncol. 2006 Dec 15;94(8):719-24.

PMID:
17131396
49.

The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion.

Chan RK, Ibrahim SI, Takahashi K, Kwon E, McCormack M, Ezekowitz A, Carroll MC, Moore FD Jr, Austen WG Jr.

J Immunol. 2006 Dec 1;177(11):8080-5.

50.

Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury.

Zhang M, Takahashi K, Alicot EM, Vorup-Jensen T, Kessler B, Thiel S, Jensenius JC, Ezekowitz RA, Moore FD, Carroll MC.

J Immunol. 2006 Oct 1;177(7):4727-34.

Supplemental Content

Loading ...
Support Center